QOLP-10. PATIENT-REPORTED OUTCOMES DURING TREATMENT FOR GLIOBLASTOMA: SYMPTOM BURDEN AND ASSOCIATED IMPACT ON DAILY LIFE

INTRODUCTION: Glioblastoma is the most common primary malignant brain tumor, with an annual incidence of 3–4 new cases per 100,000 people. Despite advances in chemotherapy, radiotherapy, and surgical interventions, prognosis remains poor. Aims of treatment for life-limiting diagnoses should extend b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Hultman, Meghan, Tipps, Megan, Liu, Minda, Banerji, Nilanjana, Bruns, Patricia, Trusheim, John
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Quality of Life and Palliative Care
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847620/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.830
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars